“Immunoregulatory factors (IRF3 and IRF7) serum levels and its relation to disease activity in Vitiligo patients”, J Pak Assoc Dermatol, vol. 33, no. 1, pp. 137–141, Mar. 2023, doi: 10.66344/jpad.33.1.2023.2053.